ASIA DUTTON: Open Payments
NPI 1457960635 · ENTERPRISE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 14 payments from 9 companies in 2025. Trend: 2023 $87 · 2024 $109 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $89 |
| Lilly USA, LLC | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
Products named: Ozempic, REXULTI, LAGEVRIO, JARDIANCE, AIRSUPRA, CAPLYTA, Cologuard Collection Kit, MOUNJARO.
Industry payments across AL — which companies pay providers there.
